SYK analyst scorecard · Stryker Corporation
48 rating actions on SYK in the last 12 months. Of 69 price targets that resolved, 6 were reached while they stood, 53 were replaced by the same firm first, and 10 fell short at their deadline. Ratings: 75% Buy-type, 25% Hold-type, 0% Sell-type. Consensus target $363, 17% above the last close.
Checked through 2026-10-29 · last close $310.36 (2026-10-29). Rebuilt every morning.
What the Holds say: 11 Hold-type ratings on SYK in the last 12 months carried a median target +9% from the price on the day; 0% sat below it.
Firm by firm
| Firm | Latest rating | Date | Latest target | Targets reached | Replaced early | Resolved | Ratings vs sector |
|---|---|---|---|---|---|---|---|
| Evercore ISI Group | Outperform | 2026-07-06 | $350 | 2 | 5 | 7 | 1 of 1 |
| BTIG | Buy | 2026-10-12 | $316 | 1 | 7 | 8 | 1 of 1 |
| Truist Securities | Hold | 2026-10-07 | $310 | 2 | 8 | 10 | — |
| Barclays | Overweight | 2026-10-07 | $375 | 0 | 5 | 5 | 1 of 1 |
| Canaccord Genuity | Buy | 2026-09-18 | $385 | 0 | 2 | 3 | 1 of 1 |
| Wolfe Research | Peer Perform | 2026-08-13 | — | — | — | 0 | — |
| BMO Capital | Outperform | 2026-07-09 | $369 | — | — | 0 | — |
| Citigroup | Buy | 2026-09-10 | $360 | 0 | 5 | 5 | 1 of 1 |
| Wells Fargo | Overweight | 2026-09-09 | $348 | 0 | 6 | 6 | 1 of 1 |
| Needham | Buy | 2026-05-01 | $418 | 0 | 8 | 8 | 1 of 1 |
| Citizens | Market Outperform | 2026-08-03 | $400 | 0 | 1 | 1 | — |
| JPMorgan | Overweight | 2026-07-31 | $350 | 0 | 2 | 3 | 1 of 1 |
| Leerink Partners | Outperform | 2026-06-05 | $407 | 0 | 1 | 1 | — |
| UBS | Neutral | 2026-03-17 | $380 | — | — | 0 | — |
| Stifel | Buy | 2026-09-30 | $330 | 0 | 0 | 1 | 0 of 1 |
| TD Cowen | Hold | 2026-09-22 | $298 | 1 | 0 | 1 | — |
| RBC Capital | Outperform | 2026-07-31 | $420 | 0 | 3 | 4 | 1 of 1 |
| Piper Sandler | Overweight | 2026-07-31 | $390 | 0 | 0 | 1 | 1 of 1 |
| Goldman Sachs | Neutral | 2026-04-09 | $357 | 0 | 0 | 1 | — |
| Bernstein | Outperform | 2026-01-09 | $465 | — | — | 0 | — |
Counts for one firm on one stock are small and move together; they are a record, not a grade. Neither the firms nor SYK carry a letter here. Why →
Every call, last 12 months
| Date | Firm | Rating | Action | Price at call | Target | Target status | Move in the 30 days before |
|---|---|---|---|---|---|---|---|
| 2026-10-12 | BTIG | Buy | maintained | $282.60 | $316 | running to 2027-10-12 | +2.5% |
| 2026-10-07 | Truist Securities | Hold | maintained | $275.40 | $310 | reached 2026-10-29 | -9.2% |
| 2026-10-07 | Barclays | Overweight | initiated | $275.40 | $375 | running to 2027-10-07 | -9.2% |
| 2026-09-30 | Stifel | Buy | maintained | $275.39 | $330 | running to 2027-09-30 | -14.9% |
| 2026-09-22 | TD Cowen | Hold | maintained | $275.09 | $298 | reached 2026-10-20 | -16.5% |
| 2026-09-18 | Canaccord Genuity | Buy | maintained | $275.12 | $385 | running to 2027-09-18 | -19.1% |
| 2026-09-10 | Citigroup | Buy | maintained | $270.01 | $360 | running to 2027-09-10 | -22.4% |
| 2026-09-09 | Wells Fargo | Overweight | maintained | $275.39 | $348 | running to 2027-09-09 | -20.4% |
| 2026-08-13 | Wolfe Research | Outperform → Peer Perform | downgrade | $341.09 | — | no target | +9.7% |
| 2026-08-03 | Citizens | Market Outperform | maintained | $341.20 | $400 | running to 2027-08-03 | +4.5% |
| 2026-07-31 | RBC Capital | Outperform | maintained | $325.70 | $420 | running to 2027-07-31 | +3.9% |
| 2026-07-31 | JPMorgan | Overweight | maintained | $325.70 | $350 | running to 2027-07-31 | +3.9% |
| 2026-07-31 | Piper Sandler | Overweight | maintained | $325.70 | $390 | running to 2027-07-31 | +3.9% |
| 2026-07-31 | Truist Securities | Hold | maintained | $325.70 | $340 | within 5% of price when set | +3.9% |
| 2026-07-31 | BTIG | Buy | maintained | $325.70 | $358 | replaced 2026-10-12, new $316 | +3.9% |
| 2026-07-09 | BMO Capital | Market Perform → Outperform | initiated | $327.11 | $369 | running to 2027-07-09 | +4.2% |
| 2026-07-06 | Evercore ISI Group | Outperform | maintained | $324.73 | $350 | reached 2026-07-29 | +6.2% |
| 2026-06-05 | Leerink Partners | Outperform | maintained | $305.66 | $407 | running to 2027-06-05 | +4.6% |
| 2026-05-04 | Truist Securities | Hold | reiterated | $290.88 | $330 | reached 2026-06-26 | -12.3% |
| 2026-05-04 | Barclays | Overweight | maintained | $290.88 | $394 | replaced 2026-10-07, new $375 | -12.3% |
| 2026-05-01 | Canaccord Genuity | Buy | maintained | $294.73 | $400 | replaced 2026-09-18, new $385 | -10.5% |
| 2026-05-01 | JPMorgan | Overweight | maintained | $294.73 | $400 | replaced 2026-07-31, new $350 | -10.5% |
| 2026-05-01 | Evercore ISI Group | Outperform | maintained | $294.73 | $355 | replaced 2026-07-06, new $350 | -10.5% |
| 2026-05-01 | Wells Fargo | Overweight | maintained | $294.73 | $418 | replaced 2026-09-09, new $348 | -10.5% |
| 2026-05-01 | Needham | Buy | maintained | $294.73 | $418 | running to 2027-05-01 | -10.5% |
| 2026-05-01 | BTIG | Buy | maintained | $294.73 | $379 | replaced 2026-07-31, new $358 | -10.5% |
| 2026-04-15 | Truist Securities | Hold | maintained | $341.24 | $380 | replaced 2026-05-04, new $330 | -2.4% |
| 2026-04-14 | BTIG | Buy | reiterated | $345.88 | $397 | replaced 2026-05-01, new $379 | +2.7% |
| 2026-04-13 | Leerink Partners | Outperform | initiated | $347.24 | $410 | replaced 2026-06-05, new $407 | +3.1% |
| 2026-04-09 | Goldman Sachs | Neutral | maintained | $339.14 | $357 | running to 2027-04-09 | -5.4% |
| 2026-04-07 | Citigroup | Buy | maintained | $332.07 | $385 | replaced 2026-09-10, new $360 | -8.9% |
| 2026-04-06 | Evercore ISI Group | Outperform | maintained | $332.30 | $365 | replaced 2026-05-01, new $355 | -8.8% |
| 2026-03-17 | UBS | Neutral | maintained | $349.11 | $380 | running to 2027-03-17 | -4.6% |
| 2026-02-24 | UBS | Neutral | maintained | $381.33 | $400 | within 5% of price when set | +7.4% |
| 2026-02-02 | Barclays | Overweight | maintained | $368.14 | $469 | replaced 2026-05-04, new $394 | +5.7% |
| 2026-01-30 | Needham | Buy | maintained | $369.56 | $454 | replaced 2026-05-01, new $418 | +5.2% |
| 2026-01-30 | BTIG | Buy | maintained | $369.56 | $412 | replaced 2026-04-14, new $397 | +5.2% |
| 2026-01-09 | Bernstein | Outperform | maintained | $367.54 | $465 | running to 2027-01-09 | +3.9% |
| 2025-12-19 | Citizens | Market Perform → Market Outperform | upgrade | $355.20 | $440 | replaced 2026-08-03, new $400 | -2.5% |
| 2025-12-18 | Truist Securities | Hold | maintained | $353.11 | $392 | replaced 2026-04-15, new $380 | -1.8% |
| 2025-12-11 | Citigroup | Buy | maintained | $352.97 | $420 | replaced 2026-04-07, new $385 | -3.0% |
| 2025-11-14 | Truist Securities | Hold | maintained | $362.22 | $400 | replaced 2025-12-18, new $392 | — |
| 2025-11-14 | Wells Fargo | Overweight | maintained | $362.22 | $456 | replaced 2026-05-01, new $418 | — |
| 2025-11-14 | Needham | Buy | reiterated | $362.22 | $448 | replaced 2026-01-30, new $454 | — |
| 2025-11-14 | BTIG | Buy | reiterated | $362.22 | $410 | replaced 2026-01-30, new $412 | — |
| 2025-11-03 | Truist Securities | Hold | reiterated | $358.16 | $392 | replaced 2025-11-14, new $400 | — |
| 2025-10-31 | Evercore ISI Group | Outperform | maintained | $356.24 | $405 | replaced 2026-04-06, new $365 | — |
| 2025-10-31 | BTIG | Buy | maintained | $356.24 | $410 | replaced 2026-01-30, new $412 | — |
Also in Medical Devices
Interactive version with the price chart and target overlay: Scorecard tab on the dashboard. All covered names: index.
How calls are checked
Every call is checked on the firm's own terms. A price target is followed until its own deadline (12 months unless the firm publishes a different horizon) and ends as reached (the stock closed at or beyond it while it stood), replaced (the same firm set a new target first) or short at deadline. A rating is compared with the stock's sector SPDR ETF on total return over the rating's life, because most big-firm ratings are relative: Overweight means "beat its peers", not "go up". Hold-type ratings are tracked, not graded. A firm is numbered only with 30+ resolved targets, and a letter prints only for a firm's whole record where an exact test separates it from a coin flip. None of this is a verdict on anyone's skill, and one day is never a grade. The full method →
Get the daily brief
Our take, the S&P 500 Pulse, the Street's calls and today's docket — one email, weekdays, 9 AM ET, 30 minutes before the open.